{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:13:23Z","timestamp":1776928403710,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>C5aR signaling plays an important role in the regulation of T cell activation and alloimmune responses in chronic graft-versus-host disease (cGVHD). However, direct evidence of this modulation and the efficacy of C5aR blockade in the treatment of cGVHD have not been demonstrated. We observed higher expression of C5aR on both monocytes and T cells of patients with cGVHD compared with healthy controls and non-GVHD patients after allogeneic hematopoietic stem cell transplantation. Our data also demonstrated a significant negative correlation between C5aR expression and regulatory T cells (Treg) frequency in cGVHD patients, indicating a potential role of C5aR in the generation and regulation of Treg. In addition, an <jats:italic>in vitro<\/jats:italic> experiment revealed C5aR deficiency promoted the development of Treg whereas C5a activation abolished the differentiation of Treg. Importantly, we found C5aR blockade by PMX53 attenuated the pathology of cGVHD and improved the survival of cGVHD mice. PMX53 had a direct regulatory effect on Treg commitment and increased TGF-\u03b21 expression. Thus, C5aR signaling may induce and intensify cGVHD by down-regulating Treg induction. The modulation of C5aR activation by PMX53 may provide a potential therapy for cGVHD.<\/jats:p>","DOI":"10.1038\/s41598-017-03700-1","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T11:41:15Z","timestamp":1497008475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Attenuation of cGVHD by C5a\/C5aR blockade is associated with increased frequency of Treg"],"prefix":"10.1038","volume":"7","author":[{"given":"Yulian","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peilong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suxia","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liye","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zesheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"3700_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nri3212","volume":"12","author":"BR Blazar","year":"2012","unstructured":"Blazar, B. R., Murphy, W. J. & Abedi, M. Advances in graft-versus-host disease biology and therapy. Nature reviews. Immunology \n                           12, 443\u2013458, doi:10.1038\/nri3212 (2012).","journal-title":"Nature reviews. Immunology"},{"key":"3700_CR2","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","volume":"365","author":"J Koreth","year":"2011","unstructured":"Koreth, J. et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. The New England journal of medicine \n                           365, 2055\u20132066, doi:10.1056\/NEJMoa1108188 (2011).","journal-title":"The New England journal of medicine"},{"key":"3700_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/bmt.2009.238","volume":"45","author":"SA Mitchell","year":"2010","unstructured":"Mitchell, S. A. et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone marrow transplantation \n                           45, 762\u2013769, doi:10.1038\/bmt.2009.238 (2010).","journal-title":"Bone marrow transplantation"},{"key":"3700_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/bmt.2014.75","volume":"49","author":"Q Ma","year":"2014","unstructured":"Ma, Q. et al. Complement component C3 mediates Th1\/Th17 polarization in human T-cell activation and cutaneous GVHD. Bone marrow transplantation \n                           49, 972\u2013976, doi:10.1038\/bmt.2014.75 (2014).","journal-title":"Bone marrow transplantation"},{"key":"3700_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MOT.0000000000000037","volume":"19","author":"CA Farrar","year":"2014","unstructured":"Farrar, C. A. & Sacks, S. H. Mechanisms of rejection: role of complement. Current opinion in organ transplantation \n                           19, 8\u201313, doi:10.1097\/MOT.0000000000000037 (2014).","journal-title":"Current opinion in organ transplantation"},{"key":"3700_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Complement: a key system for immune surveillance and homeostasis. Nature immunology \n                           11, 785\u2013797, doi:10.1038\/ni.1923 (2010).","journal-title":"Nature immunology"},{"key":"3700_CR7","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","volume":"39","author":"MK Liszewski","year":"2013","unstructured":"Liszewski, M. K. et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity \n                           39, 1143\u20131157, doi:10.1016\/j.immuni.2013.10.018 (2013).","journal-title":"Immunity"},{"key":"3700_CR8","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.4049\/jimmunol.1302417","volume":"193","author":"V Schmitz","year":"2014","unstructured":"Schmitz, V. et al. C5a and bradykinin receptor cross-talk regulates innate and adaptive immunity in Trypanosoma cruzi infection. J Immunol \n                           193, 3613\u20133623, doi:10.4049\/jimmunol.1302417 (2014).","journal-title":"J Immunol"},{"key":"3700_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.smim.2013.04.012","volume":"25","author":"M Kolev","year":"2013","unstructured":"Kolev, M., Le Friec, G. & Kemper, C. The role of complement in CD4(+) T cell homeostasis and effector functions. Seminars in immunology \n                           25, 12\u201319, doi:10.1016\/j.smim.2013.04.012 (2013).","journal-title":"Seminars in immunology"},{"key":"3700_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.molimm.2013.05.223","volume":"56","author":"C Kemper","year":"2013","unstructured":"Kemper, C. & Kohl, J. Novel roles for complement receptors in T cell regulation and beyond. Molecular immunology \n                           56, 181\u2013190, doi:10.1016\/j.molimm.2013.05.223 (2013).","journal-title":"Molecular immunology"},{"key":"3700_CR11","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.bbmt.2012.11.005","volume":"19","author":"KP MacDonald","year":"2013","unstructured":"MacDonald, K. P., Shlomchik, W. D. & Reddy, P. Biology of graft-versus-host responses: recent insights. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation \n                           19, S10\u201314, doi:10.1016\/j.bbmt.2012.11.005 (2013).","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"key":"3700_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature07021","volume":"454","author":"L Yang","year":"2008","unstructured":"Yang, L. et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature \n                           454, 350\u2013352, doi:10.1038\/nature07021 (2008).","journal-title":"Nature"},{"key":"3700_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature \n                           441, 235\u2013238, doi:10.1038\/nature04753 (2006).","journal-title":"Nature"},{"key":"3700_CR14","doi-asserted-by":"publisher","first-page":"e69779","DOI":"10.1371\/journal.pone.0069779","volume":"8","author":"N Ma","year":"2013","unstructured":"Ma, N. et al. C5a regulates IL-12+ DC migration to induce pathogenic Th1 and Th17 cells in sepsis. PloS one \n                           8, e69779, doi:10.1371\/journal.pone.0069779 (2013).","journal-title":"PloS one"},{"key":"3700_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ni.2499","volume":"14","author":"MG Strainic","year":"2013","unstructured":"Strainic, M. G., Shevach, E. M., An, F., Lin, F. & Medof, M. E. Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells. Nature immunology \n                           14, 162\u2013171, doi:10.1038\/ni.2499 (2013).","journal-title":"Nature immunology"},{"key":"3700_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fimmu.2012.00387","volume":"3","author":"JJ Grailer","year":"2012","unstructured":"Grailer, J. J., Bosmann, M. & Ward, P. A. Regulatory effects of C5a on IL-17A, IL-17F, and IL-23. Frontiers in immunology \n                           3, 387, doi:10.3389\/fimmu.2012.00387 (2012).","journal-title":"Frontiers in immunology"},{"key":"3700_CR17","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.4049\/jimmunol.1300847","volume":"190","author":"W van der Touw","year":"2013","unstructured":"van der Touw, W. et al. Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol \n                           190, 5921\u20135925, doi:10.4049\/jimmunol.1300847 (2013).","journal-title":"J Immunol"},{"key":"3700_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1182\/blood-2016-05-715896","volume":"128","author":"C McDonald-Hyman","year":"2016","unstructured":"McDonald-Hyman, C. et al. Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner. Blood \n                           128, 1013\u20131017, doi:10.1182\/blood-2016-05-715896 (2016).","journal-title":"Blood"},{"key":"3700_CR19","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1182\/blood-2014-03-562231","volume":"123","author":"R Flynn","year":"2014","unstructured":"Flynn, R. et al. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. Blood \n                           123, 3988\u20133998, doi:10.1182\/blood-2014-03-562231 (2014).","journal-title":"Blood"},{"key":"3700_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nri3225","volume":"12","author":"SH Sacks","year":"2012","unstructured":"Sacks, S. H. & Zhou, W. The role of complement in the early immune response to transplantation. Nature reviews. Immunology \n                           12, 431\u2013442, doi:10.1038\/nri3225 (2012).","journal-title":"Nature reviews. Immunology"},{"key":"3700_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-immunol-032713-120154","volume":"32","author":"VM Holers","year":"2014","unstructured":"Holers, V. M. Complement and its receptors: new insights into human disease. Annual review of immunology \n                           32, 433\u2013459, doi:10.1146\/annurev-immunol-032713-120154 (2014).","journal-title":"Annual review of immunology"},{"key":"3700_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan, A. H., Barres, B. A. & Stevens, B. The complement system: an unexpected role in synaptic pruning during development and disease. Annual review of neuroscience \n                           35, 369\u2013389, doi:10.1146\/annurev-neuro-061010-113810 (2012).","journal-title":"Annual review of neuroscience"},{"key":"3700_CR23","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin, D. & Lambris, J. D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol \n                           190, 3831\u20133838, doi:10.4049\/jimmunol.1203487 (2013).","journal-title":"J Immunol"},{"key":"3700_CR24","doi-asserted-by":"publisher","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","volume":"34","author":"M Chen","year":"2010","unstructured":"Chen, M., Daha, M. R. & Kallenberg, C. G. The complement system in systemic autoimmune disease. Journal of autoimmunity \n                           34, J276\u2013286, doi:10.1016\/j.jaut.2009.11.014 (2010).","journal-title":"Journal of autoimmunity"},{"key":"3700_CR25","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.molimm.2010.05.008","volume":"47","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger, J. R. & Song, W. C. Role and mechanism of action of complement in regulating T cell immunity. Molecular immunology \n                           47, 2176\u20132186, doi:10.1016\/j.molimm.2010.05.008 (2010).","journal-title":"Molecular immunology"},{"key":"3700_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri1994","volume":"7","author":"C Kemper","year":"2007","unstructured":"Kemper, C. & Atkinson, J. P. T-cell regulation: with complements from innate immunity. Nature reviews. Immunology \n                           7, 9\u201318, doi:10.1038\/nri1994 (2007).","journal-title":"Nature reviews. Immunology"},{"key":"3700_CR27","doi-asserted-by":"publisher","first-page":"aad1210","DOI":"10.1126\/science.aad1210","volume":"352","author":"G Arbore","year":"2016","unstructured":"Arbore, G. et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells. Science \n                           352, aad1210, doi:10.1126\/science.aad1210 (2016).","journal-title":"Science"},{"key":"3700_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.imbio.2011.07.016","volume":"217","author":"W Zhou","year":"2012","unstructured":"Zhou, W. The new face of anaphylatoxins in immune regulation. Immunobiology \n                           217, 225\u2013234, doi:10.1016\/j.imbio.2011.07.016 (2012).","journal-title":"Immunobiology"},{"key":"3700_CR29","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.4049\/jimmunol.1401322","volume":"193","author":"S Pawaria","year":"2014","unstructured":"Pawaria, S. et al. Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus. J Immunol \n                           193, 3288\u20133295, doi:10.4049\/jimmunol.1401322 (2014).","journal-title":"J Immunol"},{"key":"3700_CR30","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cam4.241","volume":"3","author":"ET Sayegh","year":"2014","unstructured":"Sayegh, E. T., Bloch, O. & Parsa, A. T. Complement anaphylatoxins as immune regulators in cancer. Cancer medicine \n                           3, 747\u2013758, doi:10.1002\/cam4.241 (2014).","journal-title":"Cancer medicine"},{"key":"3700_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.semnephrol.2013.08.007","volume":"33","author":"P Cravedi","year":"2013","unstructured":"Cravedi, P., van der Touw, W. & Heeger, P. S. Complement regulation of T-cell alloimmunity. Seminars in nephrology \n                           33, 565\u2013574, doi:10.1016\/j.semnephrol.2013.08.007 (2013).","journal-title":"Seminars in nephrology"},{"key":"3700_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2046-1682-7-5","volume":"7","author":"P Tamamis","year":"2014","unstructured":"Tamamis, P. et al. Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and docking. BMC biophysics \n                           7, 5, doi:10.1186\/2046-1682-7-5 (2014).","journal-title":"BMC biophysics"},{"key":"3700_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.smim.2016.03.006","volume":"28","author":"G Hajishengallis","year":"2016","unstructured":"Hajishengallis, G. et al. Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application. Seminars in immunology \n                           28, 285\u2013291, doi:10.1016\/j.smim.2016.03.006 (2016).","journal-title":"Seminars in immunology"},{"key":"3700_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cei.12220","volume":"175","author":"G Li","year":"2014","unstructured":"Li, G. et al. Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage. Clinical and experimental immunology \n                           175, 285\u2013295, doi:10.1111\/cei.12220 (2014).","journal-title":"Clinical and experimental immunology"},{"key":"3700_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia, M. H. et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation \n                           21, 389\u2013401 e381, doi:10.1016\/j.bbmt.2014.12.001 (2015).","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03700-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03700-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03700-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:28:46Z","timestamp":1671773326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-03700-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["3700"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-03700-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]},"assertion":[{"value":"19 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3603"}}